Sicabalo, Nelito S.

HRN: 25-90-40  Sex: Male

Patient Encounter


AMS Audit List

Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
09/20/2024
METRONIDAZOLE 5MG/ML, 100ML (VIAL)
09/20/2024
09/27/2024
IV
500mg
Q8
T/C Tetanus Infection
Waiting Final Action 
09/20/2024
CEFTRIAXONE 1G (VIAL)
09/20/2024
09/27/2024
IV
2gms
OD
T/C Tetanus Infection W/ Concomitant Infection
Waiting Final Action 
09/21/2024
CEFTRIAXONE 1G (VIAL)
09/21/2024
09/28/2024
IV
2gms
Q12
CNS Infection
Waiting Final Action 

AMS Audit Form


Start Date: End Date:

Indication:

              

Type of Infection:

                             

           

Compliance to guidelines:



Initial appropriateness:



 If inappropriate:

           

Final appropriateness:



 If inappropriate:

              

Overall appropriateness: